Oppenheimer & CO Inc Global Blood Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$22.3 - $37.39 $22,634 - $37,950	1,015 Added 8.64%	12,764 $408,000
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $10,836 - $15,018	422 Added 3.73%	11,749 $407,000
Q4 2021 Feb 02, 2022	BUY	$24.9 - $40.26 $282,042 - $456,025	11,327 New	11,327 $332,000
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $552,024 - $808,971	-21,665 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$32.46 - $43.42 $190,312 - $254,571	5,863 Added 37.1%	21,665 $759,000
Q1 2021 May 10, 2021	SELL	$38.94 - $50.85 $515,020 - $672,542	-13,226 Reduced 45.56%	15,802 $644,000
Q4 2020 Feb 11, 2021	BUY	$37.65 - $63.77 $485,722 - $822,696	12,901 Added 80.0%	29,028 $1.26 Million
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $152,740 - $215,648	-2,895 Reduced 15.22%	16,127 $889,000
Q2 2020 Aug 11, 2020	BUY	$48.73 - $81.82 $535,396 - $898,956	10,987 Added 136.74%	19,022 $1.2 Million
Q1 2020 May 08, 2020	SELL	$41.72 - $87.2 $165,461 - $345,835	-3,966 Reduced 33.05%	8,035 $411,000
Q4 2019 Feb 07, 2020	BUY	$45.7 - $81.86 $211,865 - $379,502	4,636 Added 62.95%	12,001 $954,000
Q3 2019 Oct 31, 2019	SELL	$45.35 - $57.91 $175,277 - $223,822	-3,865 Reduced 34.42%	7,365 $357,000
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $109,723 - $132,022	2,086 Added 22.81%	11,230 $591,000
Q1 2019 Apr 24, 2019	SELL	$39.99 - $53.48 $220,984 - $295,530	-5,526 Reduced 37.67%	9,144 $484,000
Q4 2018 Jan 29, 2019	SELL	$31.54 - $46.67 $38,699 - $57,264	-1,227 Reduced 7.72%	14,670 $602,000
Q3 2018 Oct 26, 2018	BUY	$38.0 - $51.1 $140,600 - $189,070	3,700 Added 30.34%	15,897 $604,000
Q2 2018 Aug 10, 2018	BUY	$38.7 - $50.15 $299,963 - $388,712	7,751 Added 174.34%	12,197 $552,000
Q1 2018 May 01, 2018	BUY	$39.6 - $65.9 $176,061 - $292,991	4,446 New	4,446 $215,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account